MMP2 and lymphangioleiomyomatosis: Serum MMP-2 was highest in LAM patients, with a median of 578 (465–832) ng/ml compared with medians of 360 (314–546) ng/ml for OCLD and 427 (365–513) ng/ml for healthy controls (p < 0.0001) (Figure 2).